Logo

Sanofi-Aventis Renews License for Genomatix Microarray Software

Sep 28, 2007
NEW YORK (GenomeWeb News) - Genomatix said yesterday that Sanofi-Aventis has renewed its multi-site license for its Microarray Analysis Pipeline software.
 
The software analyzes data for a number of micorarray applications, including gene expression, tiling microarrays, and ChIP-on-chip studies.
 
Sanofi-Aventis originally licensed the company’s GenomatixSuite software in 2005.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.